# GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

> **NCT00942136** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GSK1349572
- **DRUG:** GSK1349572
- **DRUG:** Placebo
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00942136
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942136, "GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00942136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*